Catriona Jamieson

17.5k total citations · 6 hit papers
187 papers, 12.2k citations indexed

About

Catriona Jamieson is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Catriona Jamieson has authored 187 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 81 papers in Hematology and 76 papers in Genetics. Recurrent topics in Catriona Jamieson's work include Chronic Myeloid Leukemia Treatments (62 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (40 papers) and Chronic Lymphocytic Leukemia Research (34 papers). Catriona Jamieson is often cited by papers focused on Chronic Myeloid Leukemia Treatments (62 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (40 papers) and Chronic Lymphocytic Leukemia Research (34 papers). Catriona Jamieson collaborates with scholars based in United States, Canada and Italy. Catriona Jamieson's co-authors include Irving L. Weissman, Geoffrey M. Wahl, John E. Dick, Michael F. Clarke, Peter B. Dirks, Connie J. Eaves, Jane E. Visvader, D. Leanne Jones, Derrick J. Rossi and Laurie Ailles and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Catriona Jamieson

177 papers receiving 12.0k citations

Hit Papers

Cancer Stem Cells—Perspectives on Current Status and Futu... 2004 2026 2011 2018 2006 2009 2004 2008 2009 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells
    2006 2.4k citations Catriona Jamieson, Irving L. Weissman et al. Cancer Research profile →
  2. CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
    2009 1.2k citations Siddhartha Jaiswal, Catriona Jamieson et al. Cell profile →
  3. Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML
    2004 1.1k citations Catriona Jamieson, Jason Gotlib et al. profile →
  4. Stems Cells and the Pathways to Aging and Cancer
    2008 682 citations Catriona Jamieson, Irving L. Weissman et al. Cell profile →
  5. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
    2009 676 citations Catriona Jamieson et al. profile →
  6. A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury
    2018 267 citations Catriona Jamieson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catriona Jamieson United States 42 6.7k 4.1k 3.4k 2.9k 1.9k 187 12.2k
Bruno Calabretta United States 65 8.6k 1.3× 2.6k 0.6× 3.4k 1.0× 1.9k 0.7× 1.6k 0.8× 237 13.2k
Emmanuelle Passegué United States 54 7.8k 1.2× 3.0k 0.7× 5.5k 1.6× 2.1k 0.7× 4.4k 2.2× 98 15.3k
John Groffen United States 55 6.3k 0.9× 2.1k 0.5× 5.3k 1.6× 3.6k 1.2× 1.3k 0.7× 195 13.0k
Anna Janowska‐Wieczorek Canada 46 4.5k 0.7× 2.9k 0.7× 2.4k 0.7× 2.2k 0.8× 2.6k 1.3× 129 10.0k
Atsushi Iwama Japan 64 7.6k 1.1× 2.2k 0.5× 3.6k 1.0× 1.2k 0.4× 2.5k 1.3× 251 12.1k
Jean Y. J. Wang United States 56 8.3k 1.3× 4.5k 1.1× 2.1k 0.6× 1.1k 0.4× 807 0.4× 127 11.6k
Nora Heisterkamp United States 57 6.7k 1.0× 2.4k 0.6× 7.4k 2.2× 4.9k 1.7× 1.5k 0.8× 220 15.2k
Peter Marynen Belgium 67 6.8k 1.0× 2.3k 0.6× 2.6k 0.8× 1.8k 0.6× 2.0k 1.0× 289 14.9k
Danilo Perrotti United States 50 5.9k 0.9× 1.2k 0.3× 3.2k 1.0× 1.7k 0.6× 1.3k 0.6× 123 9.0k
Dominique Bonnet United Kingdom 52 7.2k 1.1× 6.0k 1.5× 5.5k 1.6× 3.2k 1.1× 4.2k 2.2× 180 16.4k

Countries citing papers authored by Catriona Jamieson

Since Specialization
Citations

This map shows the geographic impact of Catriona Jamieson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catriona Jamieson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catriona Jamieson more than expected).

Fields of papers citing papers by Catriona Jamieson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catriona Jamieson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catriona Jamieson. The network helps show where Catriona Jamieson may publish in the future.

Co-authorship network of co-authors of Catriona Jamieson

This figure shows the co-authorship network connecting the top 25 collaborators of Catriona Jamieson. A scholar is included among the top collaborators of Catriona Jamieson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catriona Jamieson. Catriona Jamieson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Wenxue & Catriona Jamieson. (2025). Chimeric Antigen Receptor‐Macrophage Therapy Enters the Clinic: The First‐in‐Human Trial for HER2 + Solid Tumors. MedComm. 6(9). e70374–e70374. 3 indexed citations
2.
Ward, Naomi, Steven R. Bauer, Joshua Hunsberger, et al.. (2025). Biomanufacturing in low Earth orbit: A paradigm shift. Stem Cell Reports. 20(7). 102536–102536. 1 indexed citations
3.
Werf, Inge van der, et al.. (2024). RNA Modifications Shape Hematopoietic Stem Cell Aging: Beyond the Code. FEBS Letters. 598(22). 2774–2775. 1 indexed citations
4.
Botta, Gregory P., Joseph Chao, H. Ma, et al.. (2024). Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells. Journal for ImmunoTherapy of Cancer. 12(2). e007927–e007927. 15 indexed citations
5.
Pham, Jessica, Haoran Zhang, Roman Šášik, et al.. (2023). Malignant a-to-I RNA Editing By ADAR1 Drives T-Cell Acute Lymphoblastic Leukemia Relapse Via Attenuating dsRNA Sensing. Blood. 142(Supplement 1). 4147–4147. 1 indexed citations
6.
Platonova, Natalia, Elisa Lazzari, M. Colombo, et al.. (2023). The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma. International Journal of Molecular Sciences. 24(19). 14558–14558. 1 indexed citations
7.
Ryan, Joseph M., Brandon Nokes, Catriona Jamieson, et al.. (2021). Pulmonary Complications in Hematopoietic Stem Cell Transplant Recipients—A Clinician Primer. Journal of Clinical Medicine. 10(15). 3227–3227. 20 indexed citations
8.
Chen, Yun, Liguang Chen, Jian Yu, et al.. (2019). Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia. Blood. 134(13). 1084–1094. 52 indexed citations
9.
Stoner, Samuel A., Ming Yan, Katherine Liu, et al.. (2019). Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation. Blood. 134(20). 1730–1744. 12 indexed citations
10.
Ma, Wenxue, Ping Chen, Qingfei Jiang, et al.. (2017). Telomerase Inhibition Impairs Self-Renewal of ß-Catenin Activated Myeloproliferative Neoplasm Progenitors. Blood. 130. 2860. 1 indexed citations
11.
Jamieson, Catriona, Robert P. Hasserjian, Jason Gotlib, et al.. (2015). Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis. Journal of Translational Medicine. 13(1). 294–294. 31 indexed citations
12.
Mansour, Marc R., Takaomi Sanda, Lee N. Lawton, et al.. (2013). The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. The Journal of Experimental Medicine. 210(8). 1545–1557. 104 indexed citations
13.
Pardanani, Animesh, Jason Gotlib, Catriona Jamieson, et al.. (2011). Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis. Journal of Clinical Oncology. 29(7). 789–796. 310 indexed citations
14.
Goff, Daniel, Alice Shih, Angela C. Court, et al.. (2010). The Pan-Bcl-2 Family Inhibitor 97C1 Targets Blast Crisis Chronic Myeloid Leukemia Stem Cells but Spares Normal Cord Blood Progenitor Cells. Blood. 116(21). 516–516. 1 indexed citations
15.
Belanto, Joseph J., Clara E. Magyar, Michele M. Maxwell, et al.. (2010). Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation. Neuromuscular Disorders. 20(2). 111–121. 43 indexed citations
16.
Perrotti, Danilo, Catriona Jamieson, John M. Goldman, & Tomasz Skórski. (2010). Chronic myeloid leukemia: mechanisms of blastic transformation. Journal of Clinical Investigation. 120(7). 2254–2264. 289 indexed citations
17.
Jaiswal, Siddhartha, Catriona Jamieson, Wendy W. Pang, et al.. (2009). CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis. Cell. 138(2). 271–285. 1210 indexed citations breakdown →
18.
Goff, Daniel, Alice Shih, Jennifer M. Black, et al.. (2009). The Broad Spectrum Bcl-2 Inhibitor Apogossypol Induces Apoptosis and Differentiation of Blast Crisis Chronic Myeloid Leukemia Stem Cells.. Blood. 114(22). 3275–3275. 2 indexed citations
19.
Jamieson, Catriona. (2007). Cancer stem cell targeted therapy: Removing the sword of Damocles. Cancer Research. 67. 1 indexed citations
20.
Jamieson, Catriona, A E Hornby, Anna Richter, David Mitchell, & Julia G. Levy. (1993). Relative Sensitivity of Leukemic (CML) and Normal Progenitor Cells to Treatment with the Photosensitizer Benzoporphyrin Derivative and Light. Journal of Hematotherapy. 2(3). 383–386. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Calabretta Breakdown of academic impact, for papers by Emmanuelle Passegué Breakdown of academic impact, for papers by John Groffen Breakdown of academic impact, for papers by Anna Janowska‐Wieczorek Breakdown of academic impact, for papers by Atsushi Iwama Breakdown of academic impact, for papers by Jean Y. J. Wang Breakdown of academic impact, for papers by Nora Heisterkamp Breakdown of academic impact, for papers by Peter Marynen Breakdown of academic impact, for papers by Danilo Perrotti Breakdown of academic impact, for papers by Dominique Bonnet
Rankless by CCL
2026